Nicorandil ulcer: moves beyond the mucosa.
The management of wounds is a specialty in its infancy. Success requires more than the use of dressings. All wounds require a diagnosis, a point well illustrated by the management of these cases which depended solely on stopping nicorandil.
Patel
Girish K
GK
Department of Dermatology and Wound Healing, School of Medicine, Cardiff University, Cardiff, UK. patelgk@cardiff.ac.uk
Harding
Keith G
KG
D005260:Female; D006801:Humans; D008297:Male; D020108:Nicorandil / Q000009:adverse effects*; D014456:Ulcer / Q000139:chemically induced*; D014665:Vasodilator Agents / Q000009:adverse effects*; D014945:Wound Healing
D014665:Vasodilator Agents; D020108:Nicorandil
Eur J Gastroenterol Hepatol. 2006 Dec;18(12):1293-5
17099379
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003431
17054170
J Cardiovasc Pharmacol. 2002 Nov;40(5):684-92
12409977
Br J Dermatol. 2006 Aug;155(2):494-6
16882206
Ann Dermatol Venereol. 1999 Aug-Sep;126(8-9):587-90
10530345
Ann R Coll Surg Engl. 2010 Sep;92(6):W16-8
20566033
Pharmacology. 2001;63(3):154-9
11598421
Shock. 2005 Aug;24(2):103-8
16044078
J Am Coll Cardiol. 2000 Feb;35(2):514-8
10676702
Lancet. 2002 Apr 13;359(9314):1269-75
11965271
Lancet. 2002 Aug 17;360(9332):546-7
12241662
Ann R Coll Surg Engl. 2010 Sep;92(6):W39-40
20615301
Lancet. 1998 Nov 14;352(9140):1598-9
9843111
Ann R Coll Surg Engl. 2010 Sep;92(6):463-5
20819332